The presence of anti-citrullinated protein antibodies (acpa) does not affect the clinical response to adalimumab in a group of ra patients with the tumor necrosis factor (tnf) alpha-308 g/g promoter polymorphism

7

Bibliographic Details
Authors: Soto, Lilian, Sabugo, Francisca, Catalan, Diego, Wurmann, Pamela, Cermenatti, Tomas, Gatica, Hector, Aravena, Octavio, Salazar, Lorena, Carlos Aguillon, Juan, Cuchacovich, Miguel
Format: article
Status:Published version
Publication Date:2011
Country:Chile
Language:English
OAI Identifier:oai:repositorio.anid.cl:10533/127838
Online Access:https://hdl.handle.net/10533/127838
Access Level:Open access
Description
Summary:7

Similar Items